JP2016529306A5 - - Google Patents

Download PDF

Info

Publication number
JP2016529306A5
JP2016529306A5 JP2016539571A JP2016539571A JP2016529306A5 JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5 JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016539571 A JP2016539571 A JP 2016539571A JP 2016529306 A5 JP2016529306 A5 JP 2016529306A5
Authority
JP
Japan
Prior art keywords
alkyl
cyano
hydroxyl
disease
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016539571A
Other languages
English (en)
Japanese (ja)
Other versions
JP6408008B2 (ja
JP2016529306A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/069088 external-priority patent/WO2015032945A1/en
Publication of JP2016529306A publication Critical patent/JP2016529306A/ja
Publication of JP2016529306A5 publication Critical patent/JP2016529306A5/ja
Application granted granted Critical
Publication of JP6408008B2 publication Critical patent/JP6408008B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016539571A 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物 Active JP6408008B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP13183519 2013-09-09
EP13183519.1 2013-09-09
EP14151979 2014-01-21
EP14151979.3 2014-01-21
PCT/EP2014/069088 WO2015032945A1 (en) 2013-09-09 2014-09-08 Peptidyl nitril compounds as dipeptidyl peptidase i inhibitors

Publications (3)

Publication Number Publication Date
JP2016529306A JP2016529306A (ja) 2016-09-23
JP2016529306A5 true JP2016529306A5 (enExample) 2017-10-12
JP6408008B2 JP6408008B2 (ja) 2018-10-17

Family

ID=51535425

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016539571A Active JP6408008B2 (ja) 2013-09-09 2014-09-08 ジペプチジルペプチダーゼiインヒビターとしてのペプチジルニトリル化合物

Country Status (10)

Country Link
US (1) US9856228B2 (enExample)
EP (1) EP3044214B1 (enExample)
JP (1) JP6408008B2 (enExample)
CN (1) CN105612149A (enExample)
AU (1) AU2014317048B2 (enExample)
CA (1) CA2923484C (enExample)
DK (1) DK3044214T3 (enExample)
EA (1) EA029030B1 (enExample)
SG (1) SG11201601150WA (enExample)
WO (2) WO2015032943A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014317048B2 (en) 2013-09-09 2018-05-10 Neuprozyme Therapeutics ApS Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors
NO2699580T3 (enExample) 2014-01-24 2018-02-24
AU2016227618B2 (en) 2015-03-05 2020-06-04 Neuprozyme Therapeutics ApS Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors
CN107690429B (zh) 2015-04-07 2022-02-25 Ela制药有限公司 用于治疗和/或预防细胞或组织坏死的组合物,其特异性靶向组织蛋白酶c和/或cela1和/或cela3a和/或与其结构相关的酶
SI3758708T1 (sl) 2018-03-01 2025-04-30 Astrazeneca Ab Farmacevtski sestavki, ki vsebujejo (2S)-{(1S)-1-ciano-2-[4-(3-metil-2-okso-2,3-dihidro-1,3-benzoksazol-5-il)fenil]etil}-1,4-oksazepan-2-karboksamid
AU2019306532A1 (en) 2018-07-17 2021-03-04 Insmed Incorporated Certain (2S)-N-[(1S)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating Lupus Nephritis
US20230310453A1 (en) 2020-07-20 2023-10-05 Insmed, Inc. Methods for extracting neutrophil serine proteases and treating dipeptidyl peptidase 1-mediated conditions
KR20250022023A (ko) 2022-06-13 2025-02-14 알리벡시스 가부시키가이샤 아자사이클로알킬카보닐 환상 아민 화합물
CN120584108A (zh) 2023-01-06 2025-09-02 英斯梅德股份有限公司 新型可逆dpp1抑制剂及其用途
WO2025162472A1 (en) * 2024-01-31 2025-08-07 Insmed Incorporated Linear dipeptidyl peptidase 1 inhibitors and uses thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008334444B2 (en) * 2007-12-12 2011-12-15 Astrazeneca Ab Peptidyl nitriles and use thereof as dipeptidyl peptidase I inhibitors
KR100903499B1 (ko) 2007-12-27 2009-06-18 엔에이치엔비즈니스플랫폼 주식회사 검색 의도 분류에 따른 광고 제공 방법 및 상기 방법을수행하기 위한 시스템
CN102574830A (zh) * 2009-05-07 2012-07-11 阿斯利康(瑞典)有限公司 取代的1-氰基乙基杂环基甲酰胺化合物750
WO2010142985A1 (en) 2009-06-10 2010-12-16 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl]piperidin-2-ylcarboxmide compounds 761
WO2011154677A1 (en) 2010-06-09 2011-12-15 Astrazeneca Ab Substituted n-[1-cyano-2-(phenyl)ethyl] 1-aminocycloalk-1-ylcarboxamide compounds - 760
WO2012119941A1 (en) * 2011-03-04 2012-09-13 Prozymex A/S Peptidyl nitrilcompounds as peptidase inhibitors
WO2012130299A1 (en) 2011-03-30 2012-10-04 Prozymex A/S Peptidase inhibitors
US8999975B2 (en) * 2011-09-19 2015-04-07 Boehringer Ingelheim International Gmbh Substituted N- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin C
AU2014317048B2 (en) 2013-09-09 2018-05-10 Neuprozyme Therapeutics ApS Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors

Similar Documents

Publication Publication Date Title
JP2016529306A5 (enExample)
JP2018507223A5 (enExample)
JP2018535967A5 (enExample)
JP2013537203A5 (enExample)
JP2013523802A5 (enExample)
JP2018534348A5 (enExample)
JP2019524883A5 (enExample)
JP2017523225A5 (enExample)
JP2014097964A5 (enExample)
JP2010530897A5 (enExample)
JP2014511891A5 (enExample)
JP2017530959A5 (enExample)
JP2018510139A5 (enExample)
JP2015508103A5 (enExample)
JP2016510326A5 (enExample)
JP2016525130A5 (enExample)
JP2016500111A5 (enExample)
JP2020532547A5 (enExample)
JP2016540749A5 (enExample)
JP2015024998A5 (enExample)
JP2014515351A5 (enExample)
JP2014528403A5 (enExample)
JP2017514910A5 (enExample)
JP2019531279A5 (enExample)
JP2015508092A5 (enExample)